Dr. Nader Moinfar, MD

Dr. Moinfar practices at University of Virginia Physicians Group in Charlottesville, Virginia.

Dr. Moinfar's NPI, 1740206028, was assigned on July 13, 2006. Dr. Moinfar graduated from VCU School of Medicine in 1994. Dr. Moinfar holds Florida license ME80949.

Dr. Moinfar's primary practice is University of Virginia Physicians Group, at 1300 Jefferson Park Ave, Charlottesville, VA 22903 in Charlottesville City. The practice phone is (434) 295-1000.

Dr. Moinfar's primary practice is University of Virginia Physicians Group in Charlottesville, Virginia. Dr. Moinfar is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Moinfar to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moinfar practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Moinfar's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Moinfar is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Moinfar's licenses on file in 3 states: Florida, California and Virginia.

Dmand AI lists age-related macular degeneration, eye infection or inflammation, glaucoma, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion, secondary membranaous cataract surgery and surgical retina and vitreous procedures among the conditions Dr. Moinfar treats.

CMS data shows 68,606 Medicare services from Dr. Moinfar across 24 procedure codes in 2024, for 570 Medicare patients. Medicare paid $1,712,024 for them.

CMS counts 570 Medicare patients who saw Dr. Moinfar in 2024. The largest group is 75 to 84, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moinfar's median patient age at 67, with 51% women.

In 2024, Dr. Moinfar wrote 975 Medicare Part D claims for 257 patients. 65% of them were for generic drugs. CMS names the drug for 883 of them, across 18 drugs with 11 or more claims each, at $62,108 in total drug cost. In 2023, CMS named 743 claims across 16 drugs.

Dr. Moinfar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Moinfar in 2007. Dr. Moinfar's most frequent co-authors are Sabin Dang, MD, Carl Joshua Danzig, MD and David Aaron Eichenbaum, MD.

Dmand AI links Dr. Moinfar to 1 clinical trial. Open Payments lists research payments to Dr. Moinfar that name 1 trial.

CMS Open Payments shows 112 general payments to Dr. Moinfar from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Allergan Inc. paid the most, $43,043. It also lists 1 research payment totaling $181 in 2016, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Moinfar.

Dr. Moinfar graduated from VCU School of Medicine in 1994. Dr. Moinfar is a member of AAO and ASRS.

Dr. Moinfar is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.